(Q44028683)

29 November 2017

Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy (English)

1 reference

29 November 2017

1 reference

2

1 reference

29 November 2017

4

1 reference

29 November 2017

7

Röyttä M

1 reference

29 November 2017

1

Rinne JO

1 reference

29 November 2017

Eriksson KS

3

1 reference

29 November 2017

Tuomisto L

series ordinal

5

1 reference

29 November 2017

Kalimo H

series ordinal

6

1 reference

29 November 2017

Panula P

series ordinal

8

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Journal of Neurochemistry

29 November 2017

1 reference

29 November 2017

81

1 reference

29 November 2017

5

1 reference

29 November 2017

954-960

1 reference

Histamine neurons in human hypothalamus: Anatomy in normal and alzheimer diseased brains

29 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

The functional anatomy of basal ganglia disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Decrease in blood histamine in drug-treated parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Development of the histaminergic neurons and expression of histidine decarboxylase mRNA in the zebrafish brain in the absence of all peripheral histaminergic systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Striatonigral degeneration. A clinicopathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

The MPTP-treated mouse as a model of parkinsonism: how good is it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Brain histidine decarboxylase activity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Regional distribution of histamine in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Distribution of choline acetyltransferase and glutamate decarboxylase within the substantia nigra and in other brain regions from control and Parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

A histamine-containing neuronal system in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Clinical usefulness of magnetic resonance imaging in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Selegiline can mediate neuronal rescue rather than neuronal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00871.X

10.1046/J.1471-4159.2002.00871.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference